| Patents for C07D 498 - Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms (21,960) |
|---|
| 03/17/2005 | US20050059696 Process for the recovery of S -(+)-methyl- (2-chlorophenyl)- (6,7-dihydro- 4H-thieno [3,2-c] pyrid-5-yl) acetate hydrogen sulfate (clopidogrel bisulfate) from its (R) and mixture of (R) and (S)- isomers |
| 03/17/2005 | US20050059694 Antiinflammatory and antiproliferative skin agents for Topical administration of treating skin psoriasis disease; lotions, gels, cream |
| 03/17/2005 | US20050059650 1H-pyrazolo[3,4-d]pyrimidine derivatives as antidiabetic and antiobesity agent |
| 03/17/2005 | US20050058596 with neutral framework containing germanium and at least one tetravalent element other than germanium, preferably silicon, and optionally fluorine, prepared in the presence of an organonitrogen compound; absence of compensating cations makes available pore volume higher, advantageous for use as adsorbent |
| 03/17/2005 | CA2536775A1 Amorphous rapamycin 42-ester with 3-hydroxy-2-(hydroxymethyl)-2-methylpropionic acid and its pharmaceutical compositions containing the same |
| 03/16/2005 | EP1513847A2 Crystallization and purification of macrolides |
| 03/16/2005 | EP1513844A1 Novel interleukin-1 beta converting enzyme inhibitors |
| 03/16/2005 | EP1513807A1 Pharmaceutical combination |
| 03/16/2005 | EP1399436B1 Oxytocin agonists |
| 03/16/2005 | EP1392699B1 6h-oxazolo 4,5-e]indole derivatives as nicotinic acetylcholine receptor ligands and/or serotonergic ligands |
| 03/16/2005 | EP1362081B1 Acid pigment dispersants and pigment preparations |
| 03/16/2005 | EP1353929B1 Streptogramin derivatives preparation thereof and compositions containing same |
| 03/16/2005 | CN1596256A Methods for the purification of levofloxacin |
| 03/16/2005 | CN1594320A Process for preparing L-ofloxacin and ofloxacin |
| 03/15/2005 | US6867211 Fused nitrogen biheterocyclic derivatives; immunomodulaters; inhibiting cytokine release |
| 03/15/2005 | CA2321336C Synthesis of carbamate ketolide antibiotics |
| 03/15/2005 | CA2086914C Quinolone-and naphthyridone-carboxylic acid derivatives |
| 03/10/2005 | WO2005021555A1 Bicyclic piperazine compound and use thereof |
| 03/10/2005 | WO2005021515A2 Inhibitors of phosphodiesterase type-iv |
| 03/10/2005 | WO2005020894A2 Rifamycin analogs and uses thereof |
| 03/10/2005 | US20050054680 Agonists and antagonists of 5h3-like receptors of invertebrates as pesticides |
| 03/10/2005 | CA2537185A1 Inhibitors of phosphodiesterase type-iv |
| 03/10/2005 | CA2536378A1 Rifamycin analogs and uses thereof |
| 03/09/2005 | EP1512688A1 Use of K-252a derivatives for the treatment of Parkinson's disease |
| 03/09/2005 | EP1511753A2 Antimicrobial agents and uses thereof |
| 03/09/2005 | EP1511749A1 Novel interleukin-1beta converting enzyme inhibitors |
| 03/09/2005 | EP1480985B1 Salt of benzosulfonic acid containing clopidogrel and use thereof for the production of pharmaceutical formulations |
| 03/09/2005 | EP1057814B1 Tetrahydrobenzindole derivatives |
| 03/09/2005 | CN1592740A Process for the synthesis of amine ethers from secondary amino oxides and its use |
| 03/09/2005 | CN1592616A GABA enhancers in the treatment of diseases relating to reduced neurosteroid activity |
| 03/08/2005 | US6864250 N-acylated lipophilic amino acid derivatives |
| 03/03/2005 | WO2005019228A1 Isothiazoloquinolones and related compounds as anti-infective agents |
| 03/03/2005 | WO2005019226A1 A process for the recovery of substantially pure tricyclic macrolide |
| 03/03/2005 | WO2005019215A1 [1,8]naphthyridin-2-ones and related compounds for the treatment of schizophrenia |
| 03/03/2005 | WO2005018638A1 Mitotic kinesin inhibitors |
| 03/03/2005 | WO2004089958B1 Crystallization and purification of macrolides |
| 03/03/2005 | WO2004082606A8 Fused pyrrole compounds |
| 03/03/2005 | WO2004001058A3 Transcription factor modulating compounds and methods of use thereof |
| 03/03/2005 | US20050049415 Process for preparing enantiomerically pure alpha phenyl-alpha (6,7-dihydro-4h-thieno[3,2-c]pyridin-5-yl)-acetic acid derivatives |
| 03/03/2005 | US20050049271 Solubility, dissolution rate and bioavailability; X-ray diffraction peak pattern comprising broad halo at 2 theta of about 17 degrees |
| 03/03/2005 | CA2533435A1 Mitotic kinesin inhibitors |
| 03/02/2005 | EP1510501A1 IM-11 type cristalline solid and process for its preparation |
| 03/02/2005 | EP1509528A2 1,3-diaza-dibenzoazulenes as inhibitors of tumour necrosis factor production and intermediates for the preparation thereof |
| 03/02/2005 | EP1165563B1 Bicyclic heterocycles, method for producing them and their use as herbicides and pharmaceutical agents |
| 03/02/2005 | EP1073661B1 Dioxazine derivatives and their use as dyestuffs |
| 03/02/2005 | CN1589272A Process for the preparation of 2-or-9-oxa-3, 7-diazabicyclo (3.3.1) nonanes from 2-aminomethyl-2, 3-dihydrooxazines, intermediates therefore, and processes for preparing such intermediates |
| 03/02/2005 | CN1589144A Use of an ascomycin for the treatment of blepharitis |
| 03/02/2005 | CN1191252C 3-position substituted quinolone derivativers and its use in pharmacy |
| 03/02/2005 | CN1191245C Substitued cyclobutylamine derivatives |
| 03/02/2005 | CN1191236C Substituted 6,6-Hetero-dicycloderivative |
| 03/01/2005 | US6861416 New intermediates and synthetic methods for the stereospecific synthesis of oxazinone compounds, which are useful, for example, as antibiotics. The invention also pertains to novel olefinic oxazinone compounds, methods for |
| 02/24/2005 | WO2005017126A2 Oxadiazoline ligands for modulating the expression of exogenous genes via an ecdysone receptor complex |
| 02/24/2005 | WO2005016935A2 Regioselective synthesis of cci-779 |
| 02/24/2005 | WO2005016934A1 3h-phenoxazine derivatives suitable as near-infrared imaging agents, preparation an use thereof |
| 02/24/2005 | WO2005016933A1 4-biphenyl-substituted 4-substituted pyrazolidin-3,5-diones pesticide agent and/or microbicide and/or herbicide |
| 02/24/2005 | WO2005016894A1 2, 4-pyrimidinediamines useful in the treatment of neoplastic diseases, inflammatory and immune system disorders |
| 02/24/2005 | WO2005016893A2 2,4-pyrimidinediamine compounds for use in the treatment or prevention of autoimmune diseases |
| 02/24/2005 | WO2005016873A2 4-biphenylsubstituted pyrazolidin-3,5-dione derivatives |
| 02/24/2005 | WO2005016346A1 Quinazoline analogs as receptor tyrosine kinase inhibitors |
| 02/24/2005 | WO2004087056A3 BI-CYCLIC PYRIMIDINE INHIBITORS OF TGFβ |
| 02/24/2005 | WO2004085569A3 Photochromic articles that activate behind ultraviolet radiation blocking transparencies and methods for preparation |
| 02/24/2005 | WO2004046103A3 Arylpyridine compounds |
| 02/24/2005 | US20050043334 Such as N6-(4,5-dihydrooxazol-2-yl)-N4-[3-methyl-4-(6-methylpyridin-3-yloxy)-phenyl]-quinazoline-4,6-diamine; for treatment of hyperproliferative disorders such as cancer |
| 02/24/2005 | US20050043309 7-[4-(4-naphthalen-1-yl-piperazin-1-yl)-butoxy]-3,4-dihydro-1H-[1,8]naphthyridin-2-one; use in the treatment of central nervous system disorders, bipolar disorder in a human; chemical synthesis |
| 02/24/2005 | US20050043308 Process for total synthesis of ecteinascidins and intermediates therefor |
| 02/24/2005 | US20050043298 Useful for treating or preventing a variety of antibiotic resistant microbial infections; for example, 3'-hydroxy-5'-(4-ethylcarbamyl-1-piperidinyl)benzoxazinorifamycin |
| 02/24/2005 | US20050043286 Use of an ascomycin for the treatment of blepharitis |
| 02/24/2005 | US20050042771 Identifying non-drug targets; use in drug design for improving knowledge of drug-target and drug-non-target interactions, so that drug adverse reactions can be reduced or eliminated in drugs such as troglitazone, rosiglitazone, pioglitazone, methotrexate, atorvastatin, celecoxib, rofecoxib, cerivastatin |
| 02/24/2005 | CA2535873A1 3h-phenoxazine derivatives suitable as near-infrared imaging agents, preparation an use thereof |
| 02/24/2005 | CA2535868A1 4-biphenyl-substituted 4-substituted pyrazolidin-3,5-diones pesticide agent and/or microbicide and/or herbicide |
| 02/24/2005 | CA2535512A1 4-biphenylsubstituted pyrazolidin-3,5-dione derivatives |
| 02/24/2005 | CA2532988A1 Regioselective synthesis of cci-779 |
| 02/23/2005 | EP1507781A2 Process for preparing maytansinol |
| 02/23/2005 | EP1261606B1 Substituted oxazolidinones and their use in the field of blood coagulation |
| 02/23/2005 | EP1041980B1 Acyl guanidine sodium/proton exchange inhibitors and method |
| 02/23/2005 | CN1585775A 6-O-acyl ketolide derivatives of erythromycine useful as antibacterials |
| 02/23/2005 | CN1585768A Pyrazole derivatives as psychopharmaceuticals |
| 02/23/2005 | CN1585762A Pyridine derivatives as NMDA receptor ligands |
| 02/23/2005 | CN1585744A Process for the preparation of benazepril |
| 02/23/2005 | CN1585636A Use of endothelin receptor antagonists in the treatment of tumour diseases |
| 02/23/2005 | CN1583755A Photochromic compound of spiro [indolerin-phenanthroline oxazine and its preparation and use |
| 02/23/2005 | CN1583754A Indole oxazine compound and its synthesis and use |
| 02/23/2005 | CN1583753A Dioxazole pyrimidine nucleotide compounds with function of releasing NO and its use in pharmaceutics |
| 02/23/2005 | CN1583752A Synthesis of benzoxazole |
| 02/23/2005 | CN1190194C Use of macrolide compounds for treatment of dry eye |
| 02/22/2005 | US6858727 Intermediate of carbapenem antibiotics and process for the preparation thereof |
| 02/22/2005 | US6858621 Mbreast and prostate anticancer agents; viricides; alopecia |
| 02/22/2005 | US6858620 For therapy of male erectile dysfunction; female arousal disorder |
| 02/22/2005 | US6858607 7,8-fused 4H-chromene and analogs as activators of caspases and inducers of apoptosis and the use thereof |
| 02/22/2005 | US6858599 Tricyclic compound having spiro union |
| 02/22/2005 | US6858411 Recombinant nucleic acids that encode epothilone polyketide synthase (PKS) are used to express recombinant PKS genes in host cells to produce epothilone derivatives/polyketides; used as cancer drugs, fungicides and immunosuppressants |
| 02/17/2005 | WO2005014600A1 Antagonists of mcp-1 function and methods of use thereof |
| 02/17/2005 | WO2004101803A3 Process for producing anticancer agent ll-d45042 |
| 02/17/2005 | WO2004002491A8 Morpholine and tetrahydropyran drivatives and their use as cathepsin inhibitors |
| 02/17/2005 | US20050038505 Drug-delivery endovascular stent and method of forming the same |
| 02/17/2005 | US20050038068 Thienopyridones as AMPK activators for the treatment of diabetes and obesity |
| 02/17/2005 | US20050038067 A compound with azo containing mono and a bicyclic rings attached with an aryl or heteroaryl ring; both therapeutic and diagnostic |
| 02/17/2005 | US20050038064 Anticarcinogenic agents; breast, colon, lung, prostate, ovarian, and gastric cancers, leukemia, melanomas; (5R)-5-ethyl-9,10-difluoro-5-hydroxy-4,5,13,15-tetrahydro-1H,3H-oxepino[3',4':6,7]indolizino[1,2-b]quinoline-3,15-dione |
| 02/17/2005 | US20050038051 Novel molecules for regulating cell death |
| 02/17/2005 | US20050038023 Inhibitors of glycogen synthase kinase-3 (gsk-3) and aurora-2, both serine/threonine protein kinases; for treating diseases such as cancer, diabetes and alzheimer's disease |